Julia F Malalis, MD in Bethesda, MD - Medicare Ophthalmology

Julia F Malalis, MD is a medicare enrolled "Ophthalmology" physician in Bethesda, Maryland. She went to Ohio State University College Of Medicine and graduated in 2010 and has 14 years of diverse experience with area of expertise as Ophthalmology. She is a member of the group practice Capital Eye Care Llc and her current practice location is 6430 Rockledge Dr, Suite 270, Bethesda, Maryland. You can reach out to her office (for appointments etc.) via phone at (301) 493-9600.

Julia F Malalis is licensed to practice in Maryland (license number D83027) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1255642237.

Contact Information

	Julia F Malalis, MD
	6430 Rockledge Dr, Suite 270, Bethesda, MD 20817-1805
	(301) 493-9600
	(301) 493-9235

Physician's Profile

Full Name	Julia F Malalis
Gender	Female
Speciality	Ophthalmology
Experience	14 Years
Location	6430 Rockledge Dr, Bethesda, Maryland
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Julia F Malalis attended and graduated from Ohio State University College Of Medicine in 2010

NPI Data:

NPI Number: 1255642237
Provider Enumeration Date: 06/24/2010
Last Update Date: 03/29/2017

Medicare PECOS Information:

PECOS PAC ID: 0941425961
Enrollment ID: I20151008002035

Medical Identifiers

Medical identifiers for Julia F Malalis such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1255642237	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	036134551 (Illinois)	Secondary
207W00000X	Ophthalmology	D83027 (Maryland)	Primary
207W00000X	Ophthalmology	0101258767 (Virginia)	Secondary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Capital Eye Care Llc	4981947306	9

News Archive

Report identifies potentially modifiable factors that may contribute to persistent risk of SUID

An analysis of trends in sudden unexpected infant death (SUID) over the past two decades finds that the drop in such deaths that took place following release of the 1992 American Academy of Pediatrics (AAP) "back to sleep" recommendations, did not occur in infants in the first month of life.

Humana Pharmacy agrees to highest standards of transparency for prescription-drug pricing

Humana Inc. announced today that its Humana Pharmacy Solutions division is one of only five pharmacy-benefit managers (PBMs) in the U.S. to agree to the highest level of transparency for prescription-drug pricing set by the HR Policy Association.

CIOs need to identify where IT needs to be

"Chief Information Officers (CIOs) need to perform a gap analysis to identify where Information Technology (IT) needs to be, from a business and not an IT perspective," advises Greg Johnson, Chief Technology Officer at the Virginia Commonwealth University Health System. Healthcare organizations must be able to work smart, which means that virtualization, standardization and simplification of the IT environment are necessary for meeting growing organizational goals.

Inflammation enzyme regulates production of brown fat tissue

Love handles, muffin tops and stomach tires - white fat tissue forms the typical curves in the notorious problem areas to store energy. Exactly the opposite happens in brown fat tissue: Instead of being stored, energy gets transformed into heat. To the dismay of many people, adults have only small amounts of this energy burner. By contrast, babies and animals in hibernation have lots of it in their bodies where it serves for heat regulation.

Researchers evaluate mangafodipir for relief of oxaliplatin-associated neuropathies

An unfortunate side effect of the platinum-chemotherapy drug oxaliplatin is the development of neurotoxicity, which can adversely affect a patient's quality of life; therefore, the benefit of oxaliplatin-based therapy must be balanced with prevention of neuropathies. Currently, there are no therapeutic interventions available to relieve oxaliplatin-associated neurological symptoms, which are thought to be a result of reactive oxygen species-associated damage.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Julia F Malalis allows following entities to bill medicare on her behalf.

Entity Name	Champlain Ophthalmolgy Chartered
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1982722955 PECOS PAC ID: 7315012184 Enrollment ID: O20080814000080

News Archive

Report identifies potentially modifiable factors that may contribute to persistent risk of SUID

Humana Pharmacy agrees to highest standards of transparency for prescription-drug pricing

CIOs need to identify where IT needs to be

Inflammation enzyme regulates production of brown fat tissue

Researchers evaluate mangafodipir for relief of oxaliplatin-associated neuropathies

Entity Name	Capital Eye Care Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1548720394 PECOS PAC ID: 4981947306 Enrollment ID: O20190528000566

Report identifies potentially modifiable factors that may contribute to persistent risk of SUID

Humana Pharmacy agrees to highest standards of transparency for prescription-drug pricing

CIOs need to identify where IT needs to be

Inflammation enzyme regulates production of brown fat tissue

Researchers evaluate mangafodipir for relief of oxaliplatin-associated neuropathies

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Julia F Malalis is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Julia F Malalis, MD 6430 Rockledge Dr, Suite 270, Bethesda, MD 20817-1805 Ph: (301) 493-9600	Julia F Malalis, MD 6430 Rockledge Dr, Suite 270, Bethesda, MD 20817-1805 Ph: (301) 493-9600

News Archive

Report identifies potentially modifiable factors that may contribute to persistent risk of SUID

Humana Pharmacy agrees to highest standards of transparency for prescription-drug pricing

CIOs need to identify where IT needs to be

Inflammation enzyme regulates production of brown fat tissue

Researchers evaluate mangafodipir for relief of oxaliplatin-associated neuropathies

Ophthalmology Doctors in Bethesda, MD

Erwin Calvo Puente, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6720a Rockledge Dr Ste 200, Bethesda, MD 20817 Phone: 301-530-5200 Fax: 301-493-6577
Dr. Ayman Elnahry, MD, PHD Ophthalmology Medicare: Medicare Enrolled Practice Location: 9000 Rockville Pike Rm 10d45, Bethesda, MD 20892 Phone: 301-496-5248
Matias Soifer, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 9000 Rockville Pike # 10n112, Bethesda, MD 20892 Phone: 919-897-0105
Sanjeeb Bhandari, MBBS, MD, CHM, PHD Ophthalmology Medicare: Medicare Enrolled Practice Location: 10 Center Dr, Bethesda, MD 20892 Phone: 301-529-7197
Dr. Laurence Jaworski, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 10 Center Dr, Bg10 Rm10n109, Bethesda, MD 20814 Phone: 301-496-3123
Dr. Edmond Joseph Fitzgibbon, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: Bldg 49 Rm 2a50, Nei, Nih, Bethesda, MD 20892 Phone: 301-496-7144 Fax: 301-402-0511
Dr. Rosalie Lynn Bair, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 5612 Shields Dr, Bethesda, MD 20817 Phone: 301-571-4334 Fax: 301-571-4315

Julia F Malalis, MD - Medicare Ophthalmology in Bethesda, MD

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Report identifies potentially modifiable factors that may contribute to persistent risk of SUID

Humana Pharmacy agrees to highest standards of transparency for prescription-drug pricing

CIOs need to identify where IT needs to be

Inflammation enzyme regulates production of brown fat tissue

Researchers evaluate mangafodipir for relief of oxaliplatin-associated neuropathies

Medicare Reassignments

Report identifies potentially modifiable factors that may contribute to persistent risk of SUID

Humana Pharmacy agrees to highest standards of transparency for prescription-drug pricing

CIOs need to identify where IT needs to be

Inflammation enzyme regulates production of brown fat tissue

Researchers evaluate mangafodipir for relief of oxaliplatin-associated neuropathies

Report identifies potentially modifiable factors that may contribute to persistent risk of SUID

Humana Pharmacy agrees to highest standards of transparency for prescription-drug pricing

CIOs need to identify where IT needs to be

Inflammation enzyme regulates production of brown fat tissue

Researchers evaluate mangafodipir for relief of oxaliplatin-associated neuropathies

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Report identifies potentially modifiable factors that may contribute to persistent risk of SUID

Humana Pharmacy agrees to highest standards of transparency for prescription-drug pricing

CIOs need to identify where IT needs to be

Inflammation enzyme regulates production of brown fat tissue

Researchers evaluate mangafodipir for relief of oxaliplatin-associated neuropathies

Ophthalmology Doctors in Bethesda, MD